Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
40,762,262
-
Number of holders
-
101
-
Total 13F shares, excl. options
-
34,707,575
-
Shares change
-
+947,640
-
Total reported value, excl. options
-
$388,032,205
-
Value change
-
+$25,513,692
-
Put/Call ratio
-
40%
-
Number of buys
-
60
-
Number of sells
-
46
-
Price
-
$11.18
Institutional Holders of Pulmonx Corp - COM (LUNG) as of Q1 2023
As of 31 Mar 2023 Pulmonx Corp - COM (LUNG) had 137 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 34,707,575 shares of stock of the company.
Largest 10 holders included PRIMECAP MANAGEMENT CO/CA/, Point72 Asset Management, L.P., BlackRock Inc., MORGAN STANLEY, VANGUARD GROUP INC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), BRAIDWELL LP, KPCB XIII Associates, LLC, BNP PARIBAS ASSET MANAGEMENT Holding S.A., and FMR LLC.
This table shows 137 institutional shareholders of the security as of 31 Mar 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.